AAIC 2023
This site is intended for healthcare professionals
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Français New
Italiano New
Sign Up It's Free!
English Edition

Medscape

Univadis

X
Univadis from Medscape

No Results

    Tuesday, January 9, 2024
    News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

    From Medscape Psychiatry

    Coverage from the

    Alzheimer's Association International Conference (AAIC) 2023

    July 16 - 20, 2023; Amsterdam, Netherlands + Virtual

    July 16 - 20, 2023 Amsterdam, Netherlands + Virtual

    Conference News

    Medscape Psychiatry© WebMD, LLC

    Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

    Popular News From AAIC 2022

    • More Evidence Ultraprocessed Foods Detrimental for the Brain More Evidence Ultraprocessed Foods Detrimental for the Brain Adding to other recent research showing harmful effects on the brain from eating a diet rich in ultraprocessed food, new findings suggest this type of diet can accelerate cognitive decline.
      Medscape Medical News, Aug 01, 2022
    • Skin Test Accurately Identifies Alzheimer's Disease Skin Test Accurately Identifies Alzheimer's Disease A minimally invasive skin test, which measures factors related to brain connections, shows high specificity and sensitivity in new research, with diagnoses of Alzheimer disease confirmed at autopsy.
      Medscape Medical News, Aug 04, 2022
    • Negative Antiamyloid Drug Trial: Lessons Learned Negative Antiamyloid Drug Trial: Lessons Learned Although crenezumab was not superior to placebo in individuals who are at high risk for Alzheimer's disease in the API ADAD Colombia Trial, results provide important data for future studies, experts say.
      Medscape Medical News, Aug 05, 2022

    Previous Coverage

    Related Resources

    Find Us On
    About
    About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
    Membership
    Become a Member About You Professional Information Newsletters & Alerts Market Research
    App
    Medscape
    WebMD Network
    Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
    Editions
    English Deutsch Español Français Português UK
    All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.